69 days ago
Citing "disappointments" last year, Johnson & Johnson has lowered planned bonuses by 10 percent for new CEO Alex Gorsky and other top executives.
74 days ago
A jury on Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson's DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant that was later recalled.
77 days ago
In fact, as others scrambled to exit stocks in late 2008, he plunged in more - scooping up drug maker Ely Lilly and Co., health-care products giant Johnson & Johnson and food company General Mills.
83 days ago
A spokesman for the plaintiff's lawyers said the award adds to $3.35 million in compensatory damages awarded by the state Superior Court jury earlier this week.It's the first verdict in about 4...
89 days ago
Health care giant Johnson & Johnson says it's under investigation by federal prosecutors over the company's practices in marketing a line of hip replacements recalled two years ago because many...
96 days ago
Johnson & Johnson has again recalled thousands of its hip implants, 2 1/2 years after the problem-plagued health-care giant issued a recall of two other types of its artificial hips.
98 days ago
Greek prosecutors have brought criminal corruption charges related to state hospital purchases from DePuy, a subsidiary of U.S. healthcare giant Johnson & Johnson.
106 days ago
The shortage of the Johnson & Johnson injectable medication, made under contract by Ben Venue Laboratories, has continued on and off for a few years.
110 days ago
Last year, a jury found that Johnson & Johnson, through its Janssen Pharmaceuticals subsidiary, had committed Medicaid fraud and violated the state's deceptive trade practices act.
116 days ago
A lawyer for Johnson & Johnson's subsidiary, DePuy Orthopaedics, which made the implant, said Friday that the 64-year-old Kransky had many pre-existing medical ailments.
116 days ago
However, documents unsealed in the court case last week indicated that Johnson & Johnson officials were aware of problems with the device at least as far back as 2008.
119 days ago
A look at health care giant Johnson & Johnson's fourth-quarter revenue by division and for selected products and categories:
120 days ago
Higher sales helped Johnson & Johnson post a much bigger fourth-quarter profit that a year ago, when a slew of charges depressed results.
131 days ago
A panel of federal health experts has ruled that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies.
133 days ago
Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.
173 days ago
NEW CHAIRMAN: Johnson & Johnson said Friday Chairman Bill Weldon will step down in late December and be replaced by CEO Alex Gorsky.
173 days ago
Johnson & Johnson says Bill Weldon will step down as chairman at the end of next month, and its board of directors picked new CEO Alex Gorsky to replace him.